Drug Manufacturers - Specialty & Generic · Healthcare
Atul Saran
Equibles does not estimate personal net worth.
Get an email with a short summary when Emergent BioSolutions Inc. publishes a filing, an earnings call transcript or a press release.
Get EBS alertsAbout Atul Saran
Emergent BioSolutions Inc. reported in an 8-K filed March 23, 2023 that Atul Saran was terminated as Executive Vice President, Chief Strategy and Development Officer, effective March 17, 2023. Emergent BioSolutions Inc. reported in an 8-K filed January 9, 2023 that Atul Saran resigned as EVP and Chief Strategy and Development Officer, effective March 17, 2023. Emergent BioSolutions Inc. reported in an 8-K filed February 22, 2022 that Atul Saran was appointed Executive Vice President, Chief Strategy and Development Officer, effective March 1, 2022. The proxy statement of Emergent BioSolutions Inc. reports total compensation of $3,504,868 for Atul Saran in fiscal 2022, including a base salary of $574,846. Disclosed compensation is on record for 6 fiscal years. Atul Saran has spoken on 2 earnings calls across 1 company, most recently for Emergent BioSolutions Inc. on February 21, 2019. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.
“On March 17, 2023, in connection with the elimination of his position as Chief Strategy and Development Officer, the Company entered into a Separation Agreement (the "Separation Agreement") with Atul Saran.”
“Departure of Atul Saran, EVP and Chief Strategy and Development Officer, effective March 17.”
Atul Saran on recent calls
“You are correct the 30-month stay is coming up at the end of March, and we are anticipating a trial sometime later this year. The trial date has not been set, and we've had discussions with the judge in the court, but we don't have the exact timing on the scheduling yet.”
“There are patents that have been issued that are protecting the NARCAN Nasal Spray. It's something that we evaluated closely during the course of the acquisition process and came away with a strong comfort level that it will continue to help protect the NARCAN Nasal Spray as a branded product in the marketplace.”
Affiliation history
-
Emergent BioSolutions Inc. (EBS)
SEC 8-K
Current2022-03-01–present
-
Start not stated–2021-04-09
Last confirmed by a filing; no departure on record
-
Emergent BioSolutions Inc. (EBS)
Proxy statement
Start not stated–2023-03-17
Company network
Leadership on record at Emergent BioSolutions Inc.
- Daniel J. Abdun-Nabi CEO, COO, Board Member
- Joseph C. Papa CEO, Board Member
- Joseph Papa CEO, Board Member
- Robert G. Kramer, Sr. CEO, Board Member
- Zsolt Harsanyi Chairman, Board Member
- Frank Vargo CFO
- Richard S. Lindahl CFO
- Robert G. Kramer CFO
- Adam Havey COO
- Jennifer Fox General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Emergent BioSolutions Inc. (EBS) | Former Executive Vice President and Chief Strategy and Development Officer | $574,846 | $3,504,868 |
| 2021 | Emergent BioSolutions Inc. (EBS) | Former Executive Vice President and Chief Strategy and Development Officer | $553,885 | $2,070,344 |
| 2020 | Emergent BioSolutions Inc. (EBS) | Former Executive Vice President and Chief Strategy and Development Officer | $528,803 | $2,159,032 |
| 2019 | Emergent BioSolutions Inc. (EBS) | Executive Vice Presidentand Chief Strategyandand Development Officer | $503,774 | $1,862,979 |
| 2018 | Emergent BioSolutions Inc. (EBS) | Executive Vice President, Corporate Development, General Counsel and Secretary | $488,730 | $1,698,027 |
| 2017 | Emergent BioSolutions Inc. (EBS) | Executive Vice President, Corporate Development, General Counsel and Secretary | $283,179 | $1,220,554 |